Health
Anti-epileptic drug may reduce migraine aura
A new study by researchers at Lund University in Sweden found that 85% of patients with aura-dominant migraine experienced a reduction in monthly aura days by at least half following treatment with the anti-epileptic drug lamotrigine.
Summary
A new study by researchers at Lund University in Sweden found that 85% of patients with aura-dominant migraine experienced a reduction in monthly aura days by at least half following treatment with the anti-epileptic drug lamotrigine. The findings, published in the journal Frontiers in Neurology , need to be confirmed in a controlled study, but could eventually be significant for a patient group that currently lacks a specific treatment for the aura itself.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- 1967 guide for LSD use still relevant as psychedelics gain in popularityContinue reading
- Federal judge rolls back landmark disability protectionsContinue reading
- Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in USContinue reading
- Four things you need to know about deprescribingContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow